In this study, six genes (CXCL1, EREG, CCL24 (eotaxin-2), FABP4, TPM2, and SEMA3G) were selected to establish a prognostic risk assessment model for colon cancer. This evidence concerns the gene EREG and malignant colon neoplasm.